Low endotoxic activities of synthetic Salmonella-type lipid A with an additional acyloxyacyl group on the 2-amino group of beta (1-6) glucosamine disaccharide 1,4'-bisphosphate
- 1 June 1986
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 52 (3) , 872-884
- https://doi.org/10.1128/iai.52.3.872-884.1986
Abstract
A synthetic lipid A (Salmonella type, compound 516), beta (1-6)-linked D-glucosamine disaccharide 1,4'-bisphosphate, with three acyloxyacyl groups and one hydroxyacyl group, i.e., (R)-3-hexadecanoyloxytetradecanoyl, (R)-3-hydroxytetradecanoyl, (R)-3-dodecanoyloxytetradecanoyl, and (R)-3-tetradecanoyloxytetradecanoyl groups at the 2-amino, 3-hydroxyl, 2'-amino, and 3'-hydroxyl groups, respectively, was less biologically active than the synthetic Escherichia coli-type lipid A (compound 506), which has only two acyloxyacyl groups at the 2' and 3' positions and is substituted with a (R)-3-hydroxytetradecanoyl group at the 2-amino group. Compound 516 exhibited considerably weaker pyrogenic and leukopenic activity than compound 506, and it scarcely prepared rabbit skin for the Shwartzman reaction and lacked lethal toxicity on chicken embryos, although its lethal toxicity in galactosamine-loaded mice was as strong as that of compound 506. Compound 516 was also less active than compound 506 or natural E. coli lipid A (from Restrain F515) in other biological test systems, such as the Limulus test, stimulation of macrophages and lymphocytes, and interferon-inducing activity but not for interleukin-1 induction or complement activation. This observation suggests that there is an optimal number of acyloxyacyl groups on the glucosamine backbone for producing the biological activities of lipid A, especially the endotoxic activities. The 4'-monophosphate analog (compound 514) of compound 516 in general had significantly weaker activity than compound 516 in the above assays, most probably because of its greater hydrophobicity and consequently lower solubility in assay systems. Bacterial R595 lipid A derived from S. minnesota Re-mutant, which is a mixture of compounds 516 and 506, their 4'-monophosphate analogs and other compounds, exerted intermediate degrees of activity between compounds 506 and 516 in the various test systems employed.This publication has 28 references indexed in Scilit:
- A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applicationsClinica Chimica Acta; International Journal of Clinical Chemistry, 1985
- Synthetic and natural Escherichia coli free lipid A express identical endotoxic activitiesEuropean Journal of Biochemistry, 1985
- Macrophage activation by monosaccharide precursors of Escherichia coli lipid A.Proceedings of the National Academy of Sciences, 1985
- Structural studies on the lipid A component of enterobacterial lipopolysaccharides by laser desorption mass spectrometry. Location of acyl groups at the lipid A backboneEuropean Journal of Biochemistry, 1984
- Biological activities of analogues of lipid A based chemically on the revised structural modelEuropean Journal of Biochemistry, 1984
- Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins.1983
- Galactosamine-induced sensitization to the lethal effects of endotoxin.Proceedings of the National Academy of Sciences, 1979
- Endotoxic Glycolipid as a Potent Depressor of the Hepatic Drug‐Metabolizing Enzyme Systems in Mice*Microbiology and Immunology, 1979
- An endotoxin-induced serum factor that causes necrosis of tumors.Proceedings of the National Academy of Sciences, 1975
- Observations on Mode of Action of Endotoxin in Chick EmbryosExperimental Biology and Medicine, 1964